Sodium valproate induces pancreatic injury by disruption of one‐carbon metabolism
British Journal of Pharmacology · 2026
DOI: 10.1111/bph.70429 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Wenhao Cai und 18 weiteren Autor:innen. Beteiligte Einrichtung: West China Centre of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China-Liverpool Biomedical R…. Hauptthemen laut MEDLINE: Valproic Acid, Pancreatitis, Carbon, Pancreas. Die Arbeit nennt 68 Literaturangaben. Gefördert von: China Scholarship Council, West China-Liverpool Clinician Scientist Development Award, West China Hospital, Sichuan University.
Abstract (Originalsprache)
Background and Purpose Valproate medications are a leading cause of drug‐associated acute pancreatitis. This study examines how sodium valproate (Na‐VPA) induces pancreatic injury and contributes to acute pancreatitis (AP). Experimental Approach Murine pancreatic acinar cells (PACs) were treated with Na‐VPA or major VPA metabolites, and cytotoxicity was assessed by spectrofluorometry and confocal imaging. In vivo, C57BL/6 mice, with or without caerulein‐induced pancreatitis (CER‐AP), were administered Na‐VPA and pancreatic injury was evaluated. Intracellular methionine‐cycle metabolites were quantified by LC–MS/MS, whereas one‐carbon metabolism enzyme expression was determined by RT‐qPCR and western blotting. AutoDock Vina was employed to predict binding affinities of VPA to key metabolic enzymes. Key Results Na‐VPA and its metabolites induced concentration‐ and time‐dependent PAC death, independent of toxic calcium signalling. In vivo, Na‐VPA aggravated CER‐AP, increasing pancreatic histology scores and biochemical parameters. Transcriptomic and metabolomic analyses showed dysregulated one‐carbon metabolism, validated by altered mRNA and protein expression analysis of key rate‐limiting enzymes. Molecular docking indicated direct interactions between VPA and several metabolic enzymes. Na‐VPA also activated the pancreatic endoplasmic reticulum (ER) stress pathway. In PACs, Na‐VPA reduced methionine and S‐adenosylmethionine (SAM) levels, whereas supplementation with methionine or SAM markedly attenuated cell injury; conversely, ethionine exacerbated it. Moreover, SAM supplementation in vivo significantly ameliorated pancreatic damage and biochemical alterations in Na‐VPA–exacerbated CER‐AP. Conclusion and Implications Na‐VPA disrupts one‐carbon metabolism, triggering ER stress and acinar cell injury and exacerbating experimental pancreatitis. These findings provide new mechanistic insight into valproate‐associated AP and identify metabolic targets for potential prevention or therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- West China Centre of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, West China-Liverpool Biomedical Research Centre, West China Hospital, Sichuan University, Chengdu, Sich…
- Liverpool Pancreatitis Research Group, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
- Pancreas Center, First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu, China.
- MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
- Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical…
- Computational Biology Facility, University of Liverpool, Liverpool, UK.
Förderung
- China Scholarship Council
- West China-Liverpool Clinician Scientist Development Award
- West China Hospital, Sichuan University
- National Institute for Health and Care Research
- Innovative Medicines Initiative
Zitieren
APA
Cai, W., Wu, D., Li, Y., Chvanov, M., Awais, M., Forootan, S. S., Meng, X., Latawiec, D., Brown, J. P., Li, Z., He, W., Evans, A., Mukherjee, R., Szatmary, P., Criddle, D. N., Goldring, C., Huang, W., Xia, Q., & Sutton, R. (2026). Sodium valproate induces pancreatic injury by disruption of one‐carbon metabolism. British Journal of Pharmacology. https://doi.org/10.1111/bph.70429
Vancouver
Cai W, Wu D, Li Y, Chvanov M, Awais M, Forootan SS, et al. Sodium valproate induces pancreatic injury by disruption of one‐carbon metabolism. British Journal of Pharmacology. 2026. doi:10.1111/bph.70429
BibTeX
@article{Cai2026,
author = {Cai, Wenhao and Wu, Di and Li, Yuying and Chvanov, Michael and Awais, Muhammad and Forootan, Shiva Seyed and Meng, Xiaoli and Latawiec, Diane and Brown, Joseph P and Li, Ziyu and He, Wenhua and Evans, Anthony and Mukherjee, Rajarshi and Szatmary, Peter and Criddle, David N and Goldring, Chris and Huang, Wei and Xia, Qing and Sutton, Robert},
title = {Sodium valproate induces pancreatic injury by disruption of one‐carbon metabolism},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70429}
}
EUVIMED